PROGRAMME GRANTS FOR APPLIED RESEARCH
VOLUME 6 ISSUE 2 JUNE 2018
ISSN 2050-4322
Crossing the divide: a longitudinal study of effective
treatments for people with autism and attention
deficit hyperactivity disorder across the lifespan
Declan Murphy, Karen Glaser, Hannah Hayward, Hanna Eklund,
Tim Cadman, James Findon, Emma Woodhouse, Karen Ashwood,
Jennifer Beecham, Patrick Bolton, Fiona McEwen, Ellie Wilson,
Christine Ecker, Ian Wong, Emily Simonoff, Ailsa Russell, Jane McCarthy,
Eddie Chaplin, Susan Young and Philip Asherson
DOI 10.3310/pgfar06020
,
,Crossing the divide: a longitudinal study
of effective treatments for people with
autism and attention deficit hyperactivity
disorder across the lifespan
Declan Murphy,1* Karen Glaser,2 Hannah Hayward,1
Hanna Eklund,1 Tim Cadman,1 James Findon,1
Emma Woodhouse,3 Karen Ashwood,3
Jennifer Beecham,4 Patrick Bolton,5 Fiona McEwen,3,5
Ellie Wilson,1 Christine Ecker,1 Ian Wong,6
Emily Simonoff,5 Ailsa Russell,7 Jane McCarthy,8
Eddie Chaplin,1 Susan Young1 and Philip Asherson3
1Sackler Institute for Translational Neurodevelopment and Department of
Forensic and Neurodevelopmental Sciences, Institute of Psychiatry,
King’s College London, London, UK
2Institute of Gerontology, King’s College London, London, UK
3Medical Research Council Social, Genetic and Developmental Psychiatry Centre,
Institute of Psychiatry, King’s College London, London, UK
4London School of Economics and Political Science, London, UK
5Department of Child and Adolescent Psychiatry, Institute of Psychiatry,
King’s College London, London, UK
6Department of Pharmacology and Pharmacy, University of Hong Kong,
PokFuLam, Hong Kong
7Department of Psychology, University of Bath, Bath, UK
8St Andrew’s Healthcare, Northampton, UK
*Corresponding author
Declared competing interests of authors: Declan Murphy has received research funding from Shire
(Basingstoke, UK) and leads the European Union (EU) Innovative Medicines Inititative consortium EU Autism
Interventions – a Multicentre Study for Developing New Medications that receives funding from both the EU
and the European Federation of Pharmaceutical Industries and Associations. Ian Wong received a research
grant from the European Commission, Hong Kong Research Grant Council and Janssen-Cilag Ltd (High
Wycombe, UK) on research to investigate the safety of antipsychotic drugs and attention deficit hyperactivity
disorder treatments. In addition, Ailsa Russell has a patent Authors Copyright – Treatment Manual
Cognitive–Behavioural Therapy for Obsessive–Compulsive Disorder in Autism Spectrum Disorder pending.
Susan Young has received honoraria for consultancy, travel, educational talks and/or research from the
Cognitive Centre of Canada, Janssen Pharmaceutical (Raritan, NJ, USA), Eli Lilly (Indianapolis, IN, USA),
Novartis (Frimley, UK), HB Pharma (Sorø, Denmark), Flynn Pharma (Stevenage, UK) and Shire. Philip
Asherson has received honoraria for consultancy, travel, educational talks and/or research from Janssen
Pharmaceutical, Eli Lilly, Novartis, HB Pharma, Flynn Pharma and Shire.
,
